Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Escobar Cervantes

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Future Cardiology|June 1, 2018
Rivaroxaban: from ROCKET-AF trial to routine practice in SpainCarlos Escobar Cervantes
The Lancet. Diabetes & Endocrinology|July 11, 2024
SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?Carlos Escobar Cervantes
Medicina Clinica|August 6, 2021
[Direct oral anticoagulants today]Carlos Escobar Cervantes, Vivencio Barrios Alonso
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|May 10, 2021
Imaging techniques in atherosclerosisCarlos Escobar Cervantes, Leopoldo Pérez de Isla
Expert Review of Cardiovascular Therapy|March 23, 2019
Edoxaban for the prevention of stroke in patients with atrial fibrillationCarlos Escobar Cervantes, José Luis Merino, Vivencio Barrios
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|December 5, 2009
[Cabergoline in hyperprolactinemia and valvular heart disease]Marcos Lahera Vargas, Carlos Escobar Cervantes, Carmen Alameda Hernando, et al.
Archivos De Cardiologia De Mexico|December 14, 2019
Early discharge after atrial fibrillation ablationCarlos Escobar-Cervantes, Sergio Castrejón, Andreu Porta, et al.
Journal of Clinical Medicine|August 29, 2024
Hyperuricaemia Prevalence Rates According to Their Physiochemical and Epidemiological Diagnostic Criteria and Their Associations with Cardio-Renal-Metabolic Factors: SIMETAP-HU StudyAntonio Ruiz-García, Adalberto Serrano-Cumplido, Ezequiel Arranz-Martínez, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular-Kidney-Metabolic Factors: SIMETAP-AF StudyAntonio Ruiz-García, Adalberto Serrano-Cumplido, Carlos Escobar-Cervantes, et al.
Nutrients|November 27, 2024
Prevalence Rates of Abdominal Obesity, High Waist-to-Height Ratio and Excess Adiposity, and Their Associated Cardio-Kidney-Metabolic Factors: SIMETAP-AO StudyAntonio Ruiz-García, Adalberto Serrano-Cumplido, Carlos Escobar-Cervantes, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Future Cardiology|June 1, 2018
Rivaroxaban: from ROCKET-AF trial to routine practice in SpainCarlos Escobar Cervantes
The Lancet. Diabetes & Endocrinology|July 11, 2024
SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?Carlos Escobar Cervantes
Medicina Clinica|August 6, 2021
[Direct oral anticoagulants today]Carlos Escobar Cervantes, Vivencio Barrios Alonso
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|May 10, 2021
Imaging techniques in atherosclerosisCarlos Escobar Cervantes, Leopoldo Pérez de Isla
Expert Review of Cardiovascular Therapy|March 23, 2019
Edoxaban for the prevention of stroke in patients with atrial fibrillationCarlos Escobar Cervantes, José Luis Merino, Vivencio Barrios
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|December 5, 2009
[Cabergoline in hyperprolactinemia and valvular heart disease]Marcos Lahera Vargas, Carlos Escobar Cervantes, Carmen Alameda Hernando, et al.
Archivos De Cardiologia De Mexico|December 14, 2019
Early discharge after atrial fibrillation ablationCarlos Escobar-Cervantes, Sergio Castrejón, Andreu Porta, et al.
Journal of Clinical Medicine|August 29, 2024
Hyperuricaemia Prevalence Rates According to Their Physiochemical and Epidemiological Diagnostic Criteria and Their Associations with Cardio-Renal-Metabolic Factors: SIMETAP-HU StudyAntonio Ruiz-García, Adalberto Serrano-Cumplido, Ezequiel Arranz-Martínez, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular-Kidney-Metabolic Factors: SIMETAP-AF StudyAntonio Ruiz-García, Adalberto Serrano-Cumplido, Carlos Escobar-Cervantes, et al.
Nutrients|November 27, 2024
Prevalence Rates of Abdominal Obesity, High Waist-to-Height Ratio and Excess Adiposity, and Their Associated Cardio-Kidney-Metabolic Factors: SIMETAP-AO StudyAntonio Ruiz-García, Adalberto Serrano-Cumplido, Carlos Escobar-Cervantes, et al.
Pageof 6